Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 142,998 | 159,973 | 124,482 | 65,477 | 70,052 |
| Marketable Securities | 667,715 | 548,884 | 283,586 | 278,187 | 402,301 |
| Receivables | 3,903 | 11,102 | 522 | 6,921 | 1,242 |
| Inventories | 6,290 | 8,033 | 6,121 | 4,139 | 2,484 |
| Other current assets | 15,691 | 7,518 | 8,727 | 5,415 | 7,058 |
| TOTAL | $836,597 | $735,510 | $423,438 | $360,139 | $483,137 |
| Non-Current Assets | |||||
| PPE Net | 88,958 | 86,198 | 91,084 | 96,615 | 35,703 |
| Intangibles | 17,186 | 20,089 | 25,225 | 25,295 | 28,109 |
| Other Non-Current Assets | 13,068 | 5,359 | 5,939 | 2,845 | 3,528 |
| TOTAL | $119,212 | $111,646 | $122,248 | $124,755 | $67,340 |
| Total Assets | $955,809 | $847,156 | $545,686 | $484,894 | $550,477 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,882 | 4,408 | 4,879 | 3,390 | 5,645 |
| Accounts payable and accrued liabilities | 17,984 | 11,009 | 10,239 | 8,300 | 6,523 |
| Accrued Expenses | 42,753 | 34,260 | 23,279 | 27,838 | 19,220 |
| TOTAL | $115,332 | $97,812 | $74,322 | $76,112 | $105,890 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,669 | 6,542 | 7,402 | 4,125 | 5,720 |
| Deferred Revenues | 51,713 | 48,135 | 35,925 | 36,584 | 74,502 |
| Other Non-Current Liabilities | 447,231 | 221,622 | 214,540 | 215,749 | 143,912 |
| TOTAL | $582,697 | $370,954 | $288,598 | $237,348 | $200,045 |
| Total Liabilities | $698,029 | $468,766 | $362,920 | $313,460 | $305,935 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 119,018 | 117,270 | 101,827 | 100,163 | 99,579 |
| Common Shares | 118 | 116 | 102 | 100 | 99 |
| Retained earnings | -1,006,594 | -967,610 | -906,966 | -841,488 | -756,687 |
| Other shareholders' equity | 39,747 | 21,080 | 12,480 | -770 | 949 |
| TOTAL | $257,780 | $378,390 | $182,766 | $171,434 | $244,542 |
| Total Liabilities And Equity | $955,809 | $847,156 | $545,686 | $484,894 | $550,477 |